We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
106 hedge funds and large institutions have $417M invested in Lexicon Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
178% more capital invested
Capital invested by funds: $150M → $417M (+$267M)
114% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 14
53% more call options, than puts
Call options by funds: $2.26M | Put options by funds: $1.48M
16% more funds holding
Funds holding: 91 → 106 (+15)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11.09% less ownership
Funds ownership: 97.33% → 86.24% (-11%)
19% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 31
Holders
106
Holders Change
+15
Holders Change %
+16.48%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
25
Reduced
31
Closed
14
Calls
$2.26M
Puts
$1.48M
Net Calls
+$785K
Net Calls Change
+$660K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$20.9M |
| 2 |
AG
Artal Group
Luxembourg
|
+$20.9M |
| 3 |
PA
Pinnacle Associates
New York
|
+$2.87M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.58M |
| 5 |
Millennium Management
New York
|
+$1.52M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.2M |
| 2 |
Lazard Asset Management
New York
|
-$2.52M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.01M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.88M |
| 5 |
BlackRock
New York
|
-$1.84M |
